Weighing Risks and Benefits of Liraglutide -- The FDA's Review of a New Antidiabetic Therapy.

被引:204
作者
Parks, Mary [1 ]
Rosebraugh, Curtis [2 ]
机构
[1] US FDA, Div Metab & Endocrinol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[2] US FDA, Off Drug Evaluat 2, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词
COHORT;
D O I
10.1056/NEJMp1001578
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:774 / 777
页数:4
相关论文
共 4 条
  • [1] [Anonymous], GUID IND DIAB MELL E
  • [2] Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules
    Costante, Giuseppe
    Meringolo, Domenico
    Durante, Cosimo
    Bianchi, Davide
    Nocera, Maria
    Tumino, Salvatore
    Crocetti, Umberto
    Attard, Marco
    Maranghi, Marianna
    Torlontano, Massimo
    Filetti, Sebastiano
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02) : 450 - 455
  • [3] MCCONNELL EE, 1986, JNCI-J NATL CANCER I, V76, P283
  • [4] Increased Risk of Acute Pancreatitis and Biliary Disease Observed in Patients With Type 2 Diabetes A retrospective cohort study
    Noel, Rebecca A.
    Braun, Daniel K.
    Patterson, Ruth E.
    Bloomgren, Gary L.
    [J]. DIABETES CARE, 2009, 32 (05) : 834 - 838